Home » Uncategorized (Page 178)
Category Archives: Uncategorized
3 Herbs you Need to Know for Healing Depression: Interview with Sarah Josey
Depression is a condition that reportedly affects one in ten Americans. It is a conversation often avoided, but I was lucky enough to interview Sarah Josey Herbalist, Nutritionist and Founder of Golden Poppy Herbal Apothecary. She shared three herbs that everyone should know about when it comes to depression and one to avoid, while on medication. Watch video.
Find out more about Sarah Josey and Golden Poppy Herbal Apothecary at http://www.goldenpoppyherbs.com/
Join the conversation below. Have you tried any of these herbs? Let me know in the comments.
“5TH PHARMACOVIGILANCE CONGREGATION 2013–20th November 2013, Kohinoor Continental Hotel, Mumbai, India.
DRUG REGULATORY AFFAIRS INTERNATIONAL
“5TH PHARMACOVIGILANCE CONGREGATION 2013”
“Ensuring safer drugs to market by analyzing latest developments in pharmacovigilance, drug safety and risk management”
20th November 2013, Kohinoor Continental Hotel, Mumbai, India.
Greetings from Virtue Insight,
I am happy to invite you and your colleagues to be a sponsor/ delegate for our upcoming “5th Pharmacovigilance Congregation 2013” The conference will be held on 20th November 2013, Kohinoor Continental Hotel, Mumbai, India.
KEY SPEAKERS:-
- Deepa Arora, Global Head, Drug Safety & Risk Management, Lupin
- Arun Bhatt, President, Clininvent Research
- Moin Don, Executive Director, PVCON Pharmacovigilance Auditing & Consulting Services
- Bhaswat Chakraborty, Senior Vice President, Research & Development, Cadila Pharmaceuticals
- Parminder Kaur, Owner & Regulatory Affairs & PhV Consultant (QPPV), RegPak BioPharma Consulting (Netherlands, UK)
- Babita Kirodian, Head – Pharmacovigilance, Bristol-Myers Squibb
- Rajani Rokade, Head – Pharmacovigilance, Sanofi Aventis
- Veena Rajan, Head – Patient Safety, AstraZeneca
- Sofi Joseph, Head –…
View original post 465 more words
Comparing China’s And India’s Pharmaceutical Manufacturing
By Jim Zhang, Ph.D., JZMed, Inc.
The pharmaceutical markets of China and India have been experiencing such rapid growth in the past decade that they are widely recognized as two of the world’s most dynamic emerging markets. Consequently, they have attracted many drug companies around the world…………FULL ARTICLE
READ ALL AT
Jim Zhang, Ph.D., is president and managing director of JZMed, Inc., a market research company specializing in research on the Chinese pharmaceutical outsourcing industry. The company also provides consulting services for pharmaceutical outsourcing in China.

http://www.allfordrugs.com/2013/09/11/comparing-chinas-and-indias-pharmaceutical-manufacturing/
Cheminformatics, scaffolding & tuberculosis: a work in progress
One of the projects that has been keeping me busy lately is a structure data-mining exercise intended to reveal some interesting scaffold hypotheses that can contribute to research into finding new cures for tuberculosis. The process is at an early stage, but if you’re interested in taking a look at some of the preliminary results, you can view them here.
View original post 1,145 more words
Cuidado con los remedios naturales que pueden producir cáncer
Uno de los mayores errores actuales dentro de la medicina alternativa es la creencia popular de que los llamados “remedios naturales” a base de plantas son siempre beneficiosos y que nunca tienen ningún efecto secundario dañino.
View original post 904 more words
Research Perspective in Academia and Generic Pharmaceutical Industry

Rakeshwar Bandichhor
Director at Dr. Reddy’s Laboratories
Research Perspective in Academia and Generic Pharmaceutical Industry
Research per say is an exploratory endeavor that allows us to discover or invent not only medicine and material but how to make them in sustainable manner. In particular, research primarily involves identification of the target and its significance in terms of applicability to meet the societal needs ranging from education to commercial production of the goods.
| Research Perspective in Academia and Generic Pharmaceutical Industry | ||
| Rakeshwar Bandichhor* | ||
|

DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO
.....










